Zika had once been considered harmless, because about 80% of people who are infected show no symptoms. But alarms were sounded in 2015, when Brazilian officials suspected Zika as the cause of an outbreak of microcephaly brain malformation in babies. Public health . . . Continue reading →
A five-year government supported study, “Affective Neuroscience of Pediatric Bipolar Disorder,” was halted after parents complained to the University of Illinois in Chicago. According to documents obtained by ProPublica Illinois, Dr. Mani Pavuluri, a prominent psychiatrist who had founded the Pediatric Mood . . . Continue reading →
"For patients, navigating the debate can be difficult because doctors, patient advocacy groups and manufacturers often endorse positions that are in their economic self-interest." The New York Times Continue reading →
America’s profit-driven medical paradigm overdiagnoses illness and garners profits from unnecessary treatment. Continue reading →
A commentary in the April 2007 issue of HARVAD magazine, AHRP board member, Stefan Kruszeuski, MD, urges his colleagues to abandon psychiatry’s diagnostic and therapeutic reductionism.
Unreported Paxil suicides: company abandons “No Addiction” claim Sat, 10 May 2003 GlaxoSmithKline, Britain’s biggest pharmaceutical company will change the label in the UK to reflect the severe withdrawal that its antidepressant drug, Seroxat (Paxil in US) generates in many patients. In . . . Continue reading →
DANGEROUS DRUG LICENSING GAME THE FDA PLAYS Thu, 6 Mar 2003 In her column on Red Flags Weekly, Dr. Meryl Nass describes how the FDA in concert with the Justice Department have been lowering the bar for safety of drugs and vaccines . . . Continue reading →
FDA approves Paxil for Premenstrual cramps Wed, 3 Sep 2003 On September 2, the FDA approved Paxil (Seroxat) for yet another newly invented “condition.” Inasmuch as those most likely to complain about premenstrual discomfort which has been labeled, premenstrual dysphoric disorder (PMDD)–are . . . Continue reading →
Medication switched for research purposes – patient nearly dies Tue, 11 Nov 2003 The Boston Globe reports that an investigation by a state oversight agency, “uncovered numerous ethical violations at the Solomon Carter Fuller Mental Health Center by Boston Medical Center physicians . . . Continue reading →
Superiority of Zyprexa (Olanzapine) Challenged Mon, 1 Dec 2003 “The profound issue in health care is do we pay anything — regardless of the price — for a statistically significant benefit?” A major 12 month randomized study compared the effectiveness and cost . . . Continue reading →
Wolves in Sheep’s Clothing Thu, 14 Aug 2003 Dr. Sally Satel, a psychiatrist whose ready access to the national media gives her greater than ordinary influence with public health policymakers, has been described as “a conservative ideologue in a doctor’s white lab . . . Continue reading →
Drug Tested in Gulf War Is Approved for Troops_NYT Thu, 6 Feb 2003 The New York Times reports that FDA has approved the drug, pyridostigmine bromide for use by the military. The drug had been used experimentally during the Gulf War in . . . Continue reading →
